Clinical Trials Logo

Neurobehavioral Manifestations clinical trials

View clinical trials related to Neurobehavioral Manifestations.

Filter by:

NCT ID: NCT00558454 Completed - Anemia Clinical Trials

Iron Supplementation of Marginally Low Birth Weight Infants

JOHN
Start date: March 2004
Phase: Phase 4
Study type: Interventional

Iron is essential for brain development and there is a well established association between iron deficiency in infants and poor neurological development. In Sweden, about 5% of newborns have low birth weight (< 2500 g). Due to small iron stores at birth and rapid postnatal growth, they have increased risk of iron deficiency and it is therefore important to prevent iron deficiency in this population. However, excessive iron supplementation can have adverse effects in infants such as growth impairment. In a randomized, controlled trial, we are investigating the effects of 0, 1 or 2 mg/kg/d of iron on brain myelination, cognitive development and growth in low birth weight infants.

NCT ID: NCT00515294 Completed - Clinical trials for Alcohol Intoxication

Acute and Residual Effects of Caffeinated Beer

Start date: October 2006
Phase: Phase 2
Study type: Interventional

The aim of this study is to develop information about the acute and residual effects of a new product being targeted to young adults. Using a double placebo-controlled 2 X 2 factorial model study design, we will compare the acute and residual effects on driving impairment of caffeinated alcohol, non-caffeinated alcohol, caffeinated placebo, and non-caffeinated placebo. Under the alcohol conditions, participants will receive sufficient alcoholic beverage to attain a blood alcohol concentration (BAC) of .12 g%. Participants will be 144 undergraduate and graduate students, and recent college graduates.

NCT ID: NCT00391378 Completed - Stroke Clinical Trials

Cerebral Lesions and Outcome After Cardiac Surgery (CLOCS)

Start date: September 9, 2006
Phase: N/A
Study type: Observational

Between 1 and 5 percent of patients who have coronary artery bypass surgery suffer a stroke following surgery, and 30 percent have new brain lesions that do not produce symptoms and are seen only on MRI. In addition, up to 40 percent of patients develop long-term cognitive impairment. This study will identify risk factors that predict whether a person undergoing heart surgery will develop cerebral infarcts after surgery. It will also identify operative and inflammatory factors that may alter the risk, and will evaluate whether the small lesions are associated with cognitive decline at 6 months. People 18 years of age or older who will undergo coronary artery bypass surgery (CABG), heart valve replacement, or combined CABG and valve replacement procedure are eligible for this study. Candidates must have no neurological or cognitive impairment before surgery. Participants will undergo standard medical and surgical treatment as determined by their physicians. In addition, they have the following procedures: - Medical and neurological evaluation before surgery and 24 and 48 hours after surgery. - Brain MRI before surgery, and 48 hours, 30 days and 6 months after surgery. - Blood draws before surgery, immediately after surgery, and 6, 24, 48 and 72 hours after surgery to quantify the response of their inflammatory system to surgery. - Neuropsychological examinations 30 days and 6 months after surgery. - In addition, patients who agree to enroll in a substudy that will explore whether differences in the genes coding for inflammatory molecules lead to a change in the risk of iscjhemia after heart surgery, will have extra blood drawn for genetic analysis.

NCT ID: NCT00387062 Completed - Breast Cancer Clinical Trials

Computer-Based Training in Patients With Post-Chemotherapy Cognitive Impairment

Start date: October 2006
Phase: Phase 1
Study type: Interventional

The investigators hypothesize that continuous active interaction with environments that are demanding to sensory, cognitive, and motor systems, together with imbedded rewards for successful performance, will help improve memory and cognitive functioning in patients suffering from "chemobrain".

NCT ID: NCT00360633 Completed - Parkinson's Disease Clinical Trials

Psychiatric and Cognitive Manifestations of Parkinson's Disease

Start date: June 2006
Phase:
Study type: Observational

Parkinson's Disease (PD) is often thought of as affecting movement only. In fact, most patients also experience psychiatric and cognitive symptoms, sometimes from the disease itself, and sometimes as a side-effect of PD medications. The goals of this study are to evaluate the causes, effects, and clinical correlates of psychiatric and cognitive symptoms in PD.

NCT ID: NCT00247585 Completed - Sleep Clinical Trials

Hangover, Congeners, Sleep and Occupational Performance

Start date: September 2003
Phase: Phase 2
Study type: Interventional

The objective is to investigate residual effects of heavy drinking, with or without hangover symptoms. The primary aim is to test several hypotheses about residual effects of heavy drinking. Hypotheses about how heavy drinking affects next-day performance include direct physiological effects of alcohol, alcohol withdrawal effects, and non-ethanol effects, such as congeners, or family history of alcohol problems. The investigators will test the following hypotheses: 1. relative to placebo, heavy drinking will degrade next-day performance, and this relationship will be mediated in full or in part by quality of sleep; 2. a high congener alcoholic beverage will affect performance to a greater degree than a low congener beverage and this relationship will be mediated by severity of hangover symptoms.

NCT ID: NCT00183170 Completed - Clinical trials for Neurobehavioral Manifestations

Residual Effects of Intoxication on Student Performance

Start date: February 2004
Phase: Phase 2
Study type: Interventional

The primary goal of the study is to assess the residual effects of heavy drinking on academic performance. The investigators will also explore whether these effects differ by family history of alcohol abuse and hangover symptoms, as well as compare males and females with respect to these effects. The primary hypothesis is that intoxication (0.10 g% blood alcohol concentration [BAC]) with an alcoholic beverage impairs next-day academic performance, as measured by scores on quizzes, standardized academic achievement tests, and standardized neurobehavioral assessments. The secondary hypothesis is that family-history-positive individuals will show a greater performance decrement the day after heavy drinking than family-history-negative individuals.

NCT ID: NCT00125957 Completed - Depression Clinical Trials

The Effects of Wellbutrin (Bupropion) on Residual and Cognitive Symptoms in SSRI-treated Depression

Start date: August 2005
Phase: Phase 3
Study type: Interventional

Many people with depression are treated with a serotonin-specific reuptake inhibitor anti-depressant (SSRI) and feel 'better'. Although many people feel 'better', they do not feel completely 'well'. Often, individuals continue to complain of cognitive problems such as lack of attention, diminished motivation, and impaired problem-solving. This study looks at whether residual and cognitive symptoms of depression in individuals are affected by the addition of Wellbutrin (bupropion).

NCT ID: NCT00111267 Completed - Cognitive Decline Clinical Trials

Oral Vitamin B12 Supplementation and Cognitive Performance in Elderly People

Start date: May 2003
Phase: N/A
Study type: Interventional

The purpose of this trial is to study the effects of oral vitamin B12 supplementation and vitamin B12 combined with folic acid supplementation on cognitive performance for 24 weeks in elderly people with mild vitamin B12 deficiency.

NCT ID: NCT00016731 Completed - Healthy Clinical Trials

Adolescence, Puberty, and Emotion Regulation

Start date: May 29, 2001
Phase:
Study type: Observational

The purpose of this study is to use brain imaging technology to compare how the brains of adolescents and adults are activated during tasks that involve emotional responses. Evidence suggests that adolescents and adults experience activation in similar brain regions when they engage in tasks that involve the processing of emotional stimuli. However, the degree of task-associated activation may differ between adolescents and adults. This study will use functional magnetic resonance imaging (fMRI) to compare brain activation patterns in adolescents and adults. This study will also be used to develop emotion-evoking fMRI tasks to determine whether there are puberty and age-linked components of brain development.